Cargando…
Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
BACKGROUND/AIMS: The number of urinary tract infections (UTIs) caused by extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) is increasing. In an outpatient setting, there are limited therapeutic options to treat ESBL-producing pathogens. We evaluated the outcomes of amikacin outpatie...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Association of Internal Medicine
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712420/ https://www.ncbi.nlm.nih.gov/pubmed/26767869 http://dx.doi.org/10.3904/kjim.2016.31.1.156 |